These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17698703)

  • 1. Patterns of atrophy differ among specific subtypes of mild cognitive impairment.
    Whitwell JL; Petersen RC; Negash S; Weigand SD; Kantarci K; Ivnik RJ; Knopman DS; Boeve BF; Smith GE; Jack CR
    Arch Neurol; 2007 Aug; 64(8):1130-8. PubMed ID: 17698703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cortical atrophy in subgroups of mild cognitive impairment.
    Bell-McGinty S; Lopez OL; Meltzer CC; Scanlon JM; Whyte EM; Dekosky ST; Becker JT
    Arch Neurol; 2005 Sep; 62(9):1393-7. PubMed ID: 16157746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic transitions in mild cognitive impairment subtypes.
    Forlenza OV; Diniz BS; Nunes PV; Memória CM; Yassuda MS; Gattaz WF
    Int Psychogeriatr; 2009 Dec; 21(6):1088-95. PubMed ID: 19691909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive profiles in Alzheimer's disease and in mild cognitive impairment of different etiologies.
    Loewenstein DA; Acevedo A; Agron J; Issacson R; Strauman S; Crocco E; Barker WW; Duara R
    Dement Geriatr Cogn Disord; 2006; 21(5-6):309-15. PubMed ID: 16490966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
    Whitwell JL; Shiung MM; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Neurology; 2008 Feb; 70(7):512-20. PubMed ID: 17898323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia.
    Rountree SD; Waring SC; Chan WC; Lupo PJ; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(6):476-82. PubMed ID: 17992015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.
    He J; Farias S; Martinez O; Reed B; Mungas D; Decarli C
    Arch Neurol; 2009 Nov; 66(11):1393-9. PubMed ID: 19901172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Fischer P; Jungwirth S; Zehetmayer S; Weissgram S; Hoenigschnabl S; Gelpi E; Krampla W; Tragl KH
    Neurology; 2007 Jan; 68(4):288-91. PubMed ID: 17242334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.
    Karas G; Sluimer J; Goekoop R; van der Flier W; Rombouts SA; Vrenken H; Scheltens P; Fox N; Barkhof F
    AJNR Am J Neuroradiol; 2008 May; 29(5):944-9. PubMed ID: 18296551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
    Duara R; Loewenstein DA; Potter E; Appel J; Greig MT; Urs R; Shen Q; Raj A; Small B; Barker W; Schofield E; Wu Y; Potter H
    Neurology; 2008 Dec; 71(24):1986-92. PubMed ID: 19064880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter atrophy patterns of mild cognitive impairment subtypes.
    Zhang H; Sachdev PS; Wen W; Kochan NA; Crawford JD; Brodaty H; Slavin MJ; Reppermund S; Draper B; Zhu W; Kang K; Trollor JN
    J Neurol Sci; 2012 Apr; 315(1-2):26-32. PubMed ID: 22280946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment.
    Pa J; Boxer A; Chao LL; Gazzaley A; Freeman K; Kramer J; Miller BL; Weiner MW; Neuhaus J; Johnson JK
    Ann Neurol; 2009 Apr; 65(4):414-23. PubMed ID: 19399879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
    Knopman DS; Roberts RO; Geda YE; Boeve BF; Pankratz VS; Cha RH; Tangalos EG; Ivnik RJ; Petersen RC
    Arch Neurol; 2009 May; 66(5):614-9. PubMed ID: 19433661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study.
    Nordlund A; Rolstad S; Klang O; Edman A; Hansen S; Wallin A
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):541-6. PubMed ID: 19965857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.